Mouse-adapted SARS-CoV-2 Omicron BA.5 infection induces post-acute lung fibrosis in BALB/c mice
Journal of Virology · 25.11.2025 · 99 (11)
DOI: 10.1128/jvi.01406-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, erschienen am 25.11.2025. Verfasst von John M Powers und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Pulmonary Fibrosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.1, subsequent Omicron sub-lineages have continued to emerge, challenging the development of intervention and prevention strategies, including monoclonal antibodies and vaccines. To better understand the pathogenic effects caused by Omicron BA.5 infection, we developed a mouse-adapted virus with overt disease burden in BALB/c mice. Acute disease was characterized by significant weight loss and lung dysfunction following high-dose challenges. In survivor animals that were followed through 107 days post-infection, subpleural fibrosis with associated tertiary lymphoid structures was noted. Serum from these mice demonstrated potent neutralization against BA.5, with substantially reduced neutralization titers against early epidemic, zoonotic, and more recent contemporary XBB.1.5 variants. Intervention with pre-clinical monoclonal antibodies revealed that robust protection from BA.5-induced lung disease was possible after prophylactic administration. Together, this model enables the investigation of therapeutic approaches for both acute and post-acute sequelae of COVID-19. IMPORTANCE To best combat the evolving landscape of SARS-CoV-2 variants of interest and variants of concern, the development of effective small animal models is of critical importance. Herein, we describe the development of a model system in BALB/c mice to study the effects of SARS-CoV-2 BA.5 S gene in both acute and chronic disease manifestations. Intriguingly, we determined that fibrotic lung disease with tertiary lymphoid structures was a prominent feature in the lungs of mice that survived through the acute phase of infection. This is a prominent concern in human patients that survive the initial infection insult. As such, and most critically, the model system presented here provides researchers with an effective pathway in which long COVID manifestations and potential interventions can be studied.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
ORCID-Profile: John M Powers, Timothy P Sheahan, James E Crowe, Ralph S Baric
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Powers, J. M., Leist, S. R., Suryadevara, N., Zost, S. J., Binshtein, E., Abdelgadir, A., Mallory, M. L., Edwards, C. E., Gully, K. L., Hubbard, M. L., Zweigart, M. R., Bailey, A. B., Sheahan, T. P., Crowe, J. E., Montgomery, S. A., Harkema, J. R., & Baric, R. S. (2025). Mouse-adapted SARS-CoV-2 Omicron BA.5 infection induces post-acute lung fibrosis in BALB/c mice. Journal of Virology, 99(11). https://doi.org/10.1128/jvi.01406-25
Vancouver
Powers JM, Leist SR, Suryadevara N, Zost SJ, Binshtein E, Abdelgadir A, et al. Mouse-adapted SARS-CoV-2 Omicron BA.5 infection induces post-acute lung fibrosis in BALB/c mice. Journal of Virology. 2025;99(11). doi:10.1128/jvi.01406-25
BibTeX
@article{Powers2025,
author = {Powers, John M and Leist, Sarah R and Suryadevara, Naveenchandra and Zost, Seth J and Binshtein, Elad and Abdelgadir, Anfal and Mallory, Michael L and Edwards, Caitlin E and Gully, Kendra L and Hubbard, Miranda L and Zweigart, Mark R and Bailey, Alexis B and Sheahan, Timothy P and Crowe, James E and Montgomery, Stephanie A and Harkema, Jack R and Baric, Ralph S},
title = {Mouse-adapted SARS-CoV-2 Omicron BA.5 infection induces post-acute lung fibrosis in BALB/c mice},
journal = {Journal of Virology},
year = {2025},
volume = {99},
number = {11},
doi = {10.1128/jvi.01406-25}
}
EUVIMED